Diseases, Conditions, Syndromes

Age, CRP up risk for mortality in diabetes with COVID-19

(HealthDay)—For patients with diabetes and COVID-19, risk factors for mortality include older age and elevated C-reactive protein, and insulin usage is associated with poor prognosis, according to a study published online ...

Diseases, Conditions, Syndromes

New research highlights blood clot dangers of COVID-19

A special report published today in the journal Radiology outlines prevention, diagnosis and treatment of complications stemming from blood clots in patients with COVID-19. The journal also published two research letters ...

Diseases, Conditions, Syndromes

ST-segment elevation described in patients with COVID-19

(HealthDay)—For patients with COVID-19 who have ST-segment elevation, indicating potential acute myocardial infarction, there is considerable variability in presentation, and prognosis is poor, according to a letter to ...

Oncology & Cancer

Drug overcomes chemotherapy resistance in ovarian cancer

An international research team, led by scientists from Mater Research—The University of Queensland, have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which ...

Oncology & Cancer

Extra chromosomes in cancers can be good or bad

Cancer cells are notorious for their genetic disarray. A tumor cell can contain an abundance of DNA mutations and most have the wrong number of chromosomes. A missing or extra copy of a single chromosome creates an imbalance ...

Oncology & Cancer

Finding new clues to brain cancer treatment

Glioblastoma is an aggressive, killer disease. While victims of this fast-moving brain tumor comprise only about 15% of all people with brain cancer, its victims rarely survive more than a few years after diagnosis.

Oncology & Cancer

Study finds novel molecular therapeutic target for colon cancer

Researchers have found a way to help make chemotherapy more effective in treating colon cancer. They identified a new pathway (RICTOR/mTORC2) as a biological target for the disease. Targeted inhibition of RICTOR or the mTORC2 ...

page 1 from 15